Patients with multiple sites of injury or chronic widespread inflammation need the systemic approach
Fulas OA, Laferrire A, Ayoub G, Gandrath D, Mottillo C, Titi HM, et al
100 l of Ellmans reagent was added to the same tube and then the second absorbance (OD2) was measured
doi: 10.1158/2326-6066.Cir-23-1105 40 ChenJWangRLiuZFanJLiuSTanSet al
Combined with a well-formulated copper peptide serum, this creates a dual-pathway strategy: GHK-Cu provides the broad regenerative signal from the growth factor side, while Nanoretinol provides the targeted collagen-building signal from the retinoid side without either undermining the other
This ensures IV therapy is provided only when clinically appropriate and aligned with treatment objectives